Since the proposed mechanism of CTTNBP2 CRE SNV1 was to decrease a binding for a transcriptional activator, among the TFs reported by motifbreakR tool (Supplementary Table 1), we selected STAT3 because of its well-known role in several cancers [31]. The gene discussed is CTTNBP2; the disease is cancer.